Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations.

Bioorg Med Chem

BioLeap, Inc., 6350 Quadrangle Drive, Suite 110, Chapel Hill, NC 27517, United States; Conifer Point Pharmaceuticals, 3805 Old Easton Road, Doylestown, PA 18902, United States. Electronic address:

Published: August 2017

We have applied simulated annealing of chemical potential (SACP) to a diverse set of ∼150 very small molecules to provide insights into new interactions in the binding pocket of human renin, a historically difficult target for which to find low molecular weight (MW) inhibitors with good bioavailability. In one of its many uses in drug discovery, SACP provides an efficient, thermodynamically principled method of ranking chemotype replacements for scaffold hopping and manipulating physicochemical characteristics for drug development. We introduce the use of Constrained Fragment Analysis (CFA) to construct and analyze ligands composed of linking those fragments with predicted high affinity. This technique addresses the issue of effectively linking fragments together and provides a predictive mechanism to rank order prospective inhibitors for synthesis. The application of these techniques to the identification of novel inhibitors of human renin is described. Synthesis of a limited set of designed compounds provided potent, low MW analogs (ICs<100nM) with good oral bioavailability (F>20-58%).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553068PMC
http://dx.doi.org/10.1016/j.bmc.2017.05.032DOI Listing

Publication Analysis

Top Keywords

simulated annealing
8
annealing chemical
8
chemical potential
8
human renin
8
linking fragments
8
design synthesis
4
synthesis biological
4
biological evaluation
4
evaluation renin
4
inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!